Patent Assignment
Reel/Frame 061405/0353
Change of Name
Recorded: 2022-09-09
Pages: 4
Assignor
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Executed: 2022-04-01
Assignee
SUMITOMO PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 01752
Covered Property
(1)
Formulations Comprising Heterocyclic Protein Kinase Inhibitors
Application:
17/930,015 →
Publication:
US 2023/0233557
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 9, 2022
From: WARNER, STEVEN L.; SIDDIQUI-JAIN, ADAM; FLYNN, PAUL
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 061042/0574 →
Merger
Sep 9, 2022
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 061042/0688 →
Change of Name
Sep 9, 2022
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 061405/0345 →
Merger
Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →